Business Wire

Mavenir and Qualcomm to Deliver Energy Efficient, AI-Powered Massive MIMO Radio #MWC23

Share

Mavenir, the Network Software Provider building the future of networks with cloud-native solutions that run on any cloud, alongside Qualcomm Technologies, Inc., today announced the launch of its next generation OpenBeam™ massive MIMO (mMIMO) 32TRX Active Antenna Unit (AAU), featuring the Qualcomm QRU100 5G RAN Platform. The solution boasts industry-leading energy efficiency levels using AI based technology while boosting network performance to drive the transition toward modern networks by helping operators simplify and lower total cost of ownership of 5G deployments.

Mavenir’s next generation OpenBeam mMIMO 32TRX AAU, is a high-performance O-RAN based Radio Unit (O-RU) delivering 320W output power and has 192 Antenna Elements. It is designed to meet the growing demand for highly efficient and high-performance networks that can support the exponential growth in data traffic, both for RAN sharing and single operator scenarios. With a focus on Artificial Intelligence (AI) -based energy efficiency features, the AAU is key component of Mavenir’s commitment to helping reduce the carbon footprint of mobile networks.

The Qualcomm QRU100 5G RAN Platform is designed with innovation in mind. It applies leading 5G mobile expertise to support feature-rich cellular infrastructure that combines powerful performance with superior power efficiency. Combining the Qualcomm QRU100 5G RAN Platform and Mavenir’s expertise in hardware engineering and software innovation, the new solution will give operators the ability to improve coverage, increase overall network capacity, and fully realize the transformative potential of 5G.

Mavenir and Qualcomm Technologies are committed to continuing to push the boundaries of technology to deliver innovative solutions that meet the needs of their customers and support a sustainable future.

“Mavenir’s solution puts Open RAN at the forefront of radio technology, enriches the ecosystem with new players and enables us to deliver a great customer experience. Mavenir’s collaboration with Qualcomm Technologies has produced a leading solution in the market and is one that brings a new level of excellence to the Massive MIMO space in terms of energy efficiency and performance,” said Paco Martin, Head of Open RAN at Vodafone Group.

“This announcement is another key milestone in Mavenir’s commitment to delivering on the promise of Open RAN innovation,” said Pardeep Kohli, President and CEO, Mavenir. “This collaboration between Mavenir and Qualcomm Technologies has resulted in an energy efficient solution that is not just industry leading but stands out even against proprietary alternatives. Together Mavenir and Qualcomm Technologies are bringing the innovation to deliver the full potential of 5G for both public and private networks.”

"Qualcomm Technologies provides a comprehensive horizontal infrastructure platform to enable the deployment of innovative, high-performance, virtualized, and modular 5G networks at scale," said Durga Malladi, senior vice president and general manager, cellular modems and infrastructure, Qualcomm Technologies, Inc. “With the integration of the Qualcomm QRU100 5G RAN Platform, Mavenir is well positioned to set the standard for innovation and performance, outpacing traditional AAU solutions in energy efficiency and capability.”

To learn more about this collaboration, please visit Mavenir (Hall 2, Stand 2H60), Qualcomm Technologies (Hall 3, Stand 3E10), or Vodafone (Hall 3, Stand 3E11) during the show.

About Qualcomm

Qualcomm is enabling a world where everyone and everything can be intelligently connected. Our one technology roadmap allows us to efficiently scale the technologies that launched the mobile revolution – including advanced connectivity, high-performance, low-power compute, on-device intelligence and more – to the next generation of connected smart devices across industries. Innovations from Qualcomm and our family of Snapdragon platforms will help enable cloud-edge convergence, transform industries, accelerate the digital economy, and revolutionize how we experience the world, for the greater good.

Qualcomm Incorporated includes our licensing business, QTL, and the vast majority of our patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of our engineering, research and development functions, and substantially all of our products and services businesses, including our QCT semiconductor business.

About Mavenir

Mavenir is building the future of networks and pioneering advanced technology, focusing on the vision of a single, software-based automated network that runs on any cloud. As the industry's only end-to-end, cloud-native network software provider, Mavenir is focused on transforming the way the world connects, accelerating software network transformation for 250+ Communications Service Providers and Enterprises in over 120 countries, which serve more than 50% of the world’s subscribers. www.mavenir.com

Qualcomm is a trademark or register trademark of Qualcomm Incorporated.

Snapdragon and Qualcomm branded products are products of Qualcomm Technologies, Inc. and/or its subsidiaries. Qualcomm patented technologies are licensed by Qualcomm Incorporated.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Qualcomm Contacts
Pete Lancia, Corporate Communications
Phone: 1-858-845-5959
Email: corpcomm@qualcomm.com

Mauricio Lopez-Hodoyan, Investor Relations
Phone: 1-858-658-4813
Email: ir@qualcomm.com

Mavenir PR Contacts
PR@mavenir.com
Maryvonne Tubb (US)
Emmanuela Spiteri (EMEA)

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 23:06:00 EEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye